RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant
Go back to RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant| REDHILL BIO SP ADS (NASDAQ: RDHL) | Delayed: 0.78 -0.09 (10.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.87 | 52 Week High | $16.54 | |||
| Open | $0.84 | 52 Week Low | $8.10 | |||
| Day High | $0.88 | P/E | N/A | |||
| Day Low | $0.75 | EPS | $0.00 | |||
| Volume | 827,680 | |||||
